ArticleFrontiers in immunology2024

Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy.

In-Wook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.